FY15
Assets329.56
Net Worth274.21
Total Debt[●]
RevenueAnnualised basis182.95
EBITDAAnnualised basis79.18
PATAnnualised basis44.43
EBITDA Margin (%)43.28
At a glance
Updated 2026-09-29Thyrocare Technologies is an IPO with an issue size of ₹479.00 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹479.00 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗PENDINGBidding has not started yet.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets392.85₹ Cr · +99.9% vs prior year
Net Worth367.42₹ Cr · +129.5% vs prior year
FY14
Assets245.73
Net Worth206.26
Total Debt25.00
RevenueAnnualised basis149.97
EBITDAAnnualised basis75.25
PATAnnualised basis46.15
EBITDA Margin (%)50.18
FY13
Assets196.53
Net Worth160.10
Total Debt25.00
RevenueAnnualised basis134.26
EBITDAAnnualised basis69.18
PATAnnualised basis56.81
EBITDA Margin (%)51.53
31-Dec-15
Assets392.85
Net Worth367.42
Total Debt[●]
RevenueAnnualised basis175.91
EBITDAAnnualised basis76.21
PATAnnualised basis40.00
Valuation & shareholding
Post-IPO P/E.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Thyrocare Technologies IPO | — | 45.00 x | — | — |
| Rays of IPO | — | 100.84 x | — | — |
| Molbio Diagnostics IPO | — | 56.67 x | — | — |
| Manipal Health IPO | — | 84.65 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-29.
IPO UPDATE ALERTS
Register for IPO Updates →Track Thyrocare Technologies without missing an update
Register for subscription, GMP, allotment and listing notifications.